Build vs. Buy Prior Authorization Software: A 2026 Decision Guide
A build-versus-buy framework for prior authorization software covering workflow differentiation, FHIR readiness, security, maintenance, integration, and total cost.
On this page: Direct answer
Direct answer
Build vs buy prior authorization software: what operators need to know
A build-versus-buy framework for prior authorization software covering workflow differentiation, FHIR readiness, security, maintenance, integration, and total cost. Build only where the workflow creates durable strategic differentiation or unavoidable integration needs. Price policy maintenance, exceptions, monitoring, security, and support alongside development.
Building prior authorization software can create tight workflow fit, but it also makes the organization responsible for payer-rule change, interface reliability, identity and access, auditability, security, support, and every exception that appears after launch. Buying shifts part of that burden; it does not remove the need for implementation ownership.
The decision should turn on durable differentiation and operating capability, not the fact that a prototype form or language-model draft can be produced quickly.
Key takeaways
The short version
- Build only where the workflow creates durable strategic differentiation or unavoidable integration needs.
- Price policy maintenance, exceptions, monitoring, security, and support alongside development.
- Evaluate whether a configurable product plus targeted integration solves the real gap.
- Plan for CMS 2027 FHIR workflows without assuming every payer and service becomes standardized.
- Use stage gates with explicit safety, adoption, and total-cost exit criteria.
Frame the decision at capability level
A mixed answer is often strongest: buy the case-control layer, integrate with existing systems, and build only the narrow differentiator. Avoid recreating authentication, audit logs, document storage, queue mechanics, and reporting if they do not differentiate the organization.
| Capability | Build may fit | Buy may fit |
|---|---|---|
| Case workflow | Highly differentiated operating model | Configurable standard states and queues |
| Payer connectivity | Existing deep integration team and contracts | Vendor already maintains channels and standards |
| Evidence mapping | Unique proprietary data or methods | Common document and review controls |
| Analytics | Distinct enterprise data platform | Operational dashboards and exports are sufficient |
| Security/operations | Mature 24/7 product and compliance capability | Vendor controls satisfy validated requirements |
Use standards as an interface strategy, not a product strategy
CMS and ASTP/ONC are advancing FHIR-based prior authorization workflows using standards such as Coverage Requirements Discovery, Documentation Templates and Rules, Prior Authorization Support, and SMART application launch. Defined impacted payers have 2027 API requirements, and certified health IT criteria are evolving around provider support.
Standards reduce custom transport work, but they do not define your queue, data-quality gates, source trust, clinical-review policy, escalation, patient communication, or cross-channel reconciliation. Those operating decisions still determine whether the software is useful.
Build a five-part total-cost model
- 01
Create
Discovery, product design, engineering, testing, security, integrations, data migration, and initial content/rules.
- 02
Operate
Hosting, observability, support, on-call, vendor management, backups, incident response, and access administration.
- 03
Maintain
Payer, regulatory, standards, EHR, browser, model, and dependency changes.
- 04
Adopt
Workflow redesign, training, dual run, supervision, and productivity disruption.
- 05
Exit
Replacement, export, migration, archival, access termination, and open-case continuity.
Make the decision reversible
Start with a narrow workflow and architecture boundary. At each gate, compare measured completeness, processing effort, exception rate, user adoption, security findings, reliability, and cost against a configured vendor alternative. Preserve source data and exports so a pilot does not trap the organization.
Buyers should also demand reversibility: data ownership, complete audit export, standard interfaces, documented configuration, and transition support. A purchased product can create as much lock-in as custom code if the case history and rules cannot move.
Common questions
Answers before you build.
How much does it cost to build prior authorization software?+
A responsible estimate must include discovery, integrations, security, testing, payer and policy maintenance, support, monitoring, training, and replacement, not only prototype development.
Does FHIR make custom prior authorization software easy to build?+
FHIR and implementation guides can standardize parts of exchange. They do not solve local workflow, data quality, clinical governance, security operations, or nonstandard channel exceptions.
When should a provider organization build?+
Build when the capability is strategically differentiating, no configurable product can meet validated requirements, and the organization can fund durable product, integration, security, and operations ownership.
Can an organization combine bought and custom software?+
Yes. A common model is to buy the workflow foundation and use standard APIs or targeted extensions for differentiated data and process needs.
Practical closeout
Use this operator checklist.
- Build only where the workflow creates durable strategic differentiation or unavoidable integration needs.
- Price policy maintenance, exceptions, monitoring, security, and support alongside development.
- Evaluate whether a configurable product plus targeted integration solves the real gap.
- Plan for CMS 2027 FHIR workflows without assuming every payer and service becomes standardized.
- Use stage gates with explicit safety, adoption, and total-cost exit criteria.
Continue through the cluster
Verified customer case studies are added only with customer permission and supporting evidence; none is implied by these operational examples.
Sources & methodology
Trace the operational claims.
Marsa Health Editorial reviewed the primary and research sources below on July 22, 2026. We translate them into workflow controls, distinguish proposals from final rules, and flag where plan, program, state, contract, or clinical requirements vary.
- 01Electronic Prior Authorization Centers for Medicare & Medicaid ServicesCurrent CMS provider-readiness guidance for 2027 electronic prior authorization, EHR questions, FHIR testing, and workflow preparation.Accessed or rechecked July 22, 2026
- 02CMS Interoperability and Prior Authorization Final Rule CMS-0057-F Centers for Medicare & Medicaid ServicesCurrent implementation dates, decision timeframes, denial-reason requirements, metrics, and API provisions for impacted payers.Accessed or rechecked July 22, 2026
- 03Provider prior authorization API: prior authorization support ASTP/Office of the National Coordinator for Health ITCurrent health IT certification test method and standards references for provider prior authorization API capabilities.Accessed or rechecked July 22, 2026
- 04Summary of the HIPAA Security Rule U.S. Department of Health and Human ServicesCurrent Security Rule overview covering administrative, physical, and technical safeguards, access controls, risk analysis, and review of ePHI activity.Accessed or rechecked July 22, 2026
- 05Guidance on Risk Analysis U.S. Department of Health and Human ServicesOfficial guidance that risk analysis must cover all ePHI an organization creates, receives, maintains, or transmits.Accessed or rechecked July 22, 2026
- 06Health Plan Eligibility Benefit Inquiry and Response Centers for Medicare & Medicaid ServicesOfficial overview of the HIPAA-adopted X12 270/271 eligibility and benefit transaction.Accessed or rechecked July 22, 2026
Organizational author. Editorial review covers source accuracy, search intent, workflow boundaries, and human-oversight requirements. This material is educational and does not provide clinical, legal, coding, or coverage advice.
No named clinical or legal expert reviewer is attributed to this version. Marsa Health does not invent reviewer credentials.
Read our editorial methodRevision history
What changed and when
July 22, 2026
Initial publication, source review, and operational editing.